Molecular Diagnostics

Novel Blood Test Detects Colorectal Cancer Recurrence Earlier
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide, accounting for more than 600,000 deaths each year. When diagnosed early, before cancer has spread, the relative five-year survival rate for CRC is 90%, but only about 4 out of 10 CRC cases are detected early. More...05 Apr 2016

Hereditary Cancer Test Identifies Deleterious Mutations in Endometrial Cancer
Two recent studies have shown that a Hereditary Cancer test can identify deleterious mutations in patients with endometrial cancer and additionally, showed the superior ability of the combined three biomarker test to predict survival in patients with platinum treated ovarian cancer. More...05 Apr 2016

Multigene Test Identifies Early Breast Cancer
The 21-gene Recurrence Score assay, nodal status, grade, and immunohistochemical markers are recommended for chemotherapy decision making in hormone receptor positive/ human epidermal growth factor receptor negative early breast cancer. More...30 Mar 2016

Blood Test Gives Early Warning of Melanoma Relapse
Targeted immunotherapies have transformed melanoma care, extending median survival from around 9 to over 25 months but nevertheless, most patients still die of their disease and although most melanoma patients respond to treatment at first, their cancer can become resistant within a year. More...21 Mar 2016

Robust Method Developed for Microbiome Analysis
Scientists have developed a technique for genome sequence data analysis that enables to more efficiently and accurately identify differences between metagenomes for a variety of bacterial communities, which can help to study, diagnose, and treat many human diseases. In a new study, the method was successfully tested on intestinal microbiota. More...16 Mar 2016


Ultrasensitive Antibody Detection Enabled by Agglutination-PCR
Antibodies are widely used biomarkers for the diagnosis of many diseases and assays based on solid-phase immobilization of antigens comprise the majority of clinical platforms for antibody detection, but can be undermined by antigen denaturation and epitope masking. More...14 Mar 2016
In Other News
Whole-Exome Sequencing Identifies Rare Inherited Diseases
Gene Predicts Outcomes for Head and Neck Patients
Genomic Analyses Identifies Molecular Subtypes of Pancreatic Cancer
Biomarkers Help Diagnose Mild Cognitive Impairment in Diabetics
New Protocol Rapidly Detects Three Legionella Species
Blood Test Developed to Detect Five Early-Stage Cancers
Blood Test Detects All Known Inherited Heart Conditions Genes
Tumor Biopsies with Blood Monitoring Show Lesion-Specific Response
Molecular Type 2 Diabetes Biomarker Identified
Nanotechnology Helps Detects Biomarkers of Cancer
Gene Mutation Provides Clue to Vibratory Urticaria
Fast and Accurate Cystic Fibrosis Test Developed for Newborns
Listeria Hypervirulence Uncovered by Harnessing Its Biodiversity
Prognostic Biomarker Found for Colon Cancer Patients
Blood Test Improves Treatment for Acute Myeloid Leukemia
Aberrant Gene Expression Predicts Metastatic Endometrial and Lung Cancers
Fungal Infection Identified by Pathogen Detection Array Technology
Rapid Test Accurately Profiles Brain Tumor Genetics
Multiplex Quantitative Assays Detect Polyparasitism
Identification of Single Biomolecules Could Soon Be Even Faster
First-Ever Gene Identified with Biological Origin of Schizophrenia
Inherited Gene Mutation Leads to Ovarian Cancer
Rapid Diagnostic Assay for Ebola Field Tested
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.